Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 25, 829–830 (1 August 2007) | doi:10.1038/nbt0807-829
Ann Arbor community rallies in wake of Pfizer shutdown
Abstract
The closing of Pfizer's Ann Arbor, Michigan, research facility, announced in January, has affected over 2,100 of the pharma firm's employees. Many have turned adversity into opportunity, however, finding jobs at smaller firms in the area or creating new companies from scratch—with nearly 30 startups launched to date.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
